|
1. Ackermann, E. J., Kempner, E. S. and Dennis, E. A. (1994) Ca2+-independent cytosolic phospholipase A2 from macrophage-like P388D1 cells. Isolation and characterization. J. Biol. Chem. 269, 9227-9233. 2. Akashi, M., Loussararian, A.H., Adelman, D.C., Saito, M. and Koeffler, H.P. (1990) Role of lymphotoxin in expression of interleukin 6 in human fibroblasts. Stimulation and regulation. J. Clin. Invest. 85, 121-129. 3. Allsup, D.J and Boarder, M.R. (1990) Comparison of P2 purinergic receptors of aortic endothelial cells with those of adrenal medulla: evidence for heterogeneity of recepotr subtype and inositol phhosphate response. Mol. Pharmacol. 38, 84-91. 4. Anderson G.D., Hauser S.D., McGarity, K.L., Bremer M.E. and Isakson P.C. (1997) Gregory SA. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J. Clin. Invest. 97, 2673-2679. 5. Anderson, R.J., Breckon, R. and Dixon, B.S. (1991) ATP receptor regulation of adenylate cyclase and protein kinase C activity in cultured renal LLC-PK1 cells. J. Clin. Invest. 87: 1732-1738. 6. Arbibe, L., Vial, D., Rosinski-Chupi, I., Havet, N., Huerre, M., Vargoftig, B. B. and Touqui, L. (1997) Endotoxin induced expression of type II phospholipase A2 in macrophages during acute lung injury in guinea pigs: involvement of TNF- in lipopolysaccharide-induced type II phospholipase A2 synthesis. J. Immunol. 159, 391-400. 7. Arunlakshana, O. and Schild, H.O. (1959) Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother. 14, 48-57. 8. Astin, M., Stjemschantz, J. and Selen, G. (1994) Role of nitric oxide in PGF2-induced ocular hyperemia. Exp. Eye Res. 59, 401-407. 9. Aurivillius, M., Hansen, O.C., Lazrek, M.B., Bock, E. and Obrink, B. (1990) The cell adhesion molecule Cell-CAM 105 is an ecto-ATPase and a member of the immunoglobulin superfamily. FEBS Lett. 264, 267-269. 10. Axelrod, J., Burck, R. M. and Jelsema, C. L. (1988) Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: arachidonic acid and its metabolites as second messengers. Trends Neurosci. 11, 117-123. 11. Baeuerle, P.A., and Henkel, T. (1994) Function and activation of NF-B in the immune system. Ann. Rev. Immunol. 12, 141-179. 12. Bailey, S.J. and Hourani, S.M.O. (1994) Different effects of suramin on P2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder. Br. J. Pharmacol. 112, 219-225. 13. Baldwin, A.S.Jr. (1996) The NF-B and IB proteins: new discoveries and insights. Ann. Rev. Immunol. 14, 649-681. 14. Barker, J. E., Anderson, J., Treasure, T. and Piper, P. J. (1994) Effects of prostaglandins on stimulated release of nitric oxide by angiotensin II from human saphenous vein. Br. J. Pharmacol. 112 (Suppl), 446P. 15. Barnard, E.A., Burnstock, G. and Webb, T.E. (1994) G protein-coupled receptors for ATP and other nucleotides: a new receptor family. Trends Pharmacol. Sci. 15, 67-70. 16. Bauer, M. K. A., Lieb, K., Schulze-Osthoff, K., Berger, M., Gebicke-Haerter, P. J., Bauer, J. and Fiebich, B. L. (1997) Expression and regulation of cyclooxgenase-2 in rat microglia. Eur. J. Biochem. 243, 726-731. 17. Beasley, D. (1997) Phorbol ester and interleukin-1 induce interleukin-6 gene expression in vascular smooth muscle cells via independent pathways. J. Cardiovasc. Pharmacol. 29, 323-330. 18. Beltman, J., McCormick, F. and Cook, S.J. (1996) The selective protein kinase C inhibitor, Ro-31-8220, inhibits mitogen-activated protein kinase phosphatase-1(MKP-1) expression, induces c-Jun expression, and activates Jun N-terminal kinase. J. Biol. Chem. 271, 27018-27024. 19. Benbernou, N., Esnault, S., Shin, H. C. K., Fekkar, H. and Guenounou, M. (1997) Differential regulation of IFN-, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway. Immunology 91, 361-368. 20. Berridge, M.J. (1987) Inositol trisphosphate and diacylglycerol: two interacting second messengers. Ann. Rev. Biochem. 56, 159-193. 21. Bertrand, G., Chapal, J. and Loubatieres-Mariani, M.M. (1986) Potentiating synergism between adenosine diphosphate or triphosphate and acetylcholine on insulin secretion. Am. J. Physiol. 251, E416-421. 22. Bertrand, G., Chapal, J. and Loubatieres-Mariani, M.M. and Roye, M. (1987) Evidence for two different P2-purinoceptors on cells and pancreatic vascular bed. Br. J. Pharmacol. 91, 783-787. 23. Bertrand, G., Chapal, J., Puech, R. and Loubatieres-Mariani, M.M. (1991) Adenosine-5’-O-(2-thiodiphosphate) is a potent agonist at P2 purinoceptors mediating insulin secretion from perfused rat pancreas. Br. J. Pharmacol. 102, 627-630. 24. Bertrand, G., Gross, R., Chapal, J. and Loubatieres-Mariani, M.M. (1989) Difference in the potentiating effect of adenosine triphosphate and ,-methylene-ATP on the biphasic insulin response to glucose. Br. J. Pharmacol. 98, 998-1004. 25. Beukers, M. W., Kerkhof, C.J.M., van Rhee, M.A., Ardanuy, U., Gurgel, C., Widjaja, H., Nickel, P., Ijzerman, A.P. and Soudijn, W. (1995) Suramin analogs, divalent cations and ATPS as inhibitors of ecto-ATPase. Naunyn-Schmiedeberg’s Arch. Pharmacol. 351, 523-528. 26. Beukers, M.W., Pirovano, I.M., van Weert, A., Kerkhof, C.J.M., Ijzerman, A.P. and Soudiji, W. (1993) Characterization of ecto-ATPase on human blood cells. A physiological role in platelet aggregation?. Biochem. Pharmacol. 46, 1959-1966. 27. Beyaert, R., Cuenda, A., Berghe, W., Plaisance, S., Lee, J., Haegeman, G., Cohn, P., and Fiers, W. (1996) The p38 mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumor necrosis factor. EMBO J. 15, 1914-1923. 28. Blank, V., Kourilsky, P. and Israel, A. (1992) NF-B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem. Sci. 17, 135-140. 29. Boarder, M.R. and Hourani, S.M. (1998) The regulation of vascular function by P2 receptors: multiple sites and multiple receptors. Trends Pharmacol. Sci., 19, 99-107. 30. Boarder, M.R., Weisman, G.A., Turner, J.T. and Wilkinson, G.F. (1995) G protein-coupled P2 purinoceptors: from molecular biology to functional responses. Trends Pharmacol. Sci. 16, 133-139. 31. Boeynaems, J.M. and Galand N. (1983) Stimulation of vascular prostacyclin synthesis by extracellular ADP and ATP. Biochem. Biophys. Res. Commun. 112, 290-296. 32. Boeynaems, J.M. and Pearson, J.D. (1990) P2 purinoceptors on vascular endothelial cells: physiological significance and transduction mechnisms. Trends. Pharmacol. Sci. 11, 34-37. 33. Born, G.V.R. and Kratzer, M.A.A. (1984) Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man. J. Physiol. Lond., 354, 419-429. 34. Boutherin-Falson, O., Reuse, S., Dumont, J.E. and Boeynaems, J.-M. (1990) Increased levels of c-fos and c-myc mRNA in ATP-stimulated endothelial cells. Biochem. Biophys. Res. Commun., 172, 306-312. 35. Bouvier, M. (1992) Cross-talk between second messengers. Ann. New York Acad. Sci. 594, 120-129. 36. Boyer, J.L., Lazarowski, E.R., Chen, X. H. and Harden, T.K. (1993) Identification of a P2Y-purinergic receptor that inhibits adenylyl cyclase. J. Pharmacol. Exp. Ther. 267, 1140-1146. 37. Boyer, J.L., Zohn, I.E., Jackson, K.A. and Harden, T.K. (1994) Differential effects of P2-purinoceptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y-purinoceptors. Br. J. Pharmacol. 113, 614-620. 38. Briner, V.A. and Kern, F. (1994) ATP stimulates Ca2+ mobilization by a nucleotide receptor in glomerular endothelial cells. Am. J. Physiol. 366, F210-217. 39. Brown, C.A., Patel, V., Wilkinson, G. and Boarder, M.R. (1996) P2 purinoceptor-stimulated conversion of arginine to citrulline in bovine endothelial cells is reduced by inhibition of protein kinase C. Biochem. Pharmacol. 52, 1849-1854. 40. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., and Siebenlist, U. (1995) Control of IB- proteolysis by site-specific, signal-induced phosphorylation. Science 267, 1485-1488. 41. Buchmuller-Rouiller, Y., Betz-Corradin, S., and Mauel, J. (1992) Differential effect of prostaglandins on macrophage activation induced by calcium ionophore A23187 or IFN-. J. Immunol. 148, 1171-1175. 42. Buell, G., Michel, A.D., Lewis, C., Collo, G. Humphrey, P.P,A., and Surprenant, A. (1996) P2X1 receptor activation in HL60 cells. Blood 87, 2659-2664. 43. Bultmann, R., Driessen, B., Goncalves, J. and Starke, K. (1995) Functional consequences of inhibition of nucleotide breakdown in rat vas deferens: a study with Evans blue. Naunyn-Schmiedebergs Arch. Pharmacol. 351, 555-560. 44. Burnstock, G. (1978) A basis for distinguishing two types of purinergic receptor. In cell membrane receptors for drugs and hormones. A multidiscriplinary apporach, edited by Staub, R.W. and Bolis, L. New York: Raven, P. 107-118. 45. Burnstock, G. and Kennedy, C. (1985) Is there a basis for distinguishing two types of P2-purinoceptors? Gen. Pharmacol. 16, 433-440. 46. Burnstock, G. and Warloand, J.J. (1987) P2-purinoceptors of two subtypes in the rabbit mesenteric artery: reactive blue 2 selectively inhibits responses mediated via the P2Y- but not the P2X-purinoceptor. Br. J. Pharmacol. 90, 383-391. 47. Callery, M.P., Mangino, M.J., Kamei, T. and Flye, M.W. (1990) Interleukin-6 production by endotoxin-stimulated Kupffer cells is regulated by prostaglandin E2. J. Surg. Res. 48, 523-527. 48. Candela, J.L.R. and Garcia-Fernandez, M.C. (1963) Stimulation of secretion of insulin by adenosine-triphosphate. Nature 197, 1210 (Abstract). 49. Caselmann, W.H. (1995) Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis. J. Hepatol. 22 (Suppl 1), 34-37. 50. Castro, E., Tome, A.R., Miras-portugal, M.T. and Rosario, L.M. (1994) Single-cell fura-2 microfluorometry reveals different purinoceptor subtypes coupled to Ca2+ influx and intracellular Ca2+ release in bovine adrenal chromaffin and endothelial cells. Pflugers. Arch. 426, 524-533. 51. Celada, A., Gray, P.W., Rinderknecht, F., and Schreiber, R.D. (1984) Evidence for a interferon- receptor that regulated macrophage tumoricidal activity. J. Exp. Med. 160, 55-74. 52. Chang, K., Hanaoka, K. Kumada, M., and Takuwa, Y. (1995) Molecular cloning and functional analysis of a novel P2 nucleotide receptor. J. Biol. Chem. 270, 26152-26158. 53. Channon, Y.T. and Leslie, C.C. (1990) A calcium-dependent mechanism for associating a soluble arachidonyl-hydrolyzing phospholipase A2 with membrane in the macrophage cell line RAW 264.7. J. Biol. Chem. 265, 5409-5413. 54. Chen J. and Iyengar, R. (1993) Inhibition of cloned adenylyl cyclases by mutant-activated Gi-alpha and specific suppression of type 2 adenylyl cyclase inhibition by phorbol ester treatment. J. Biol. Chem. 268, 12253-12256. 55. Chen, B. C., Chou, C. F. and Lin, W. W. (1998) Pyrimidinoceptor-mediated potentiation of iNOS induction in J774 macrophages: role of intracellular calcium. J. Biol. Chem. 273, 29754-29763. 56. Chen, B.C., Chen, Y.H., and Lin, W.W. (1999) Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages. Immunology 97, 124-129. 57. Chen, B.C., Lee, C.M. and Lin, W.W. (1996) Characterization of signaling pathway of P2Y and P2U purinoceptors in bovine pulmonary artery endothelial cells. J. Cardiovasc. Pharmacol., 28, 192-199. 58. Chen, B.C., Lee, C.M. and Lin, W.W. (1996) Inhibition of ecto-ATPase by PPADS, suramin and reactive blue in endothelial cells, C6 glioma cells and RAW 264.7 macrophages. Br. J. Pharmacol. 119, 1628-1634. 59. Chen, B.C., Lee, C.-M., Lee, Y.T. and Lin, W.W. (1996) Characterization of signalling pathways of P2Y and P2U purinoceptors in bovine pulmonary artery endothelial cells. J. Cardiovasc. Pharmacol. 28, 192-199. 60. Chen, B.C., Lin, L.L. and Lin, W.W. (1999) PKC-dependent pathway of ERK activation by P2Y1 and P2Y2 purinoceptors that activate cPLA2 in endothelial cells. Eur. J. Pharmacol.373, 101-110. 61. Chen, Z. J., Parent, L., and Maniatis, T. (1996) Site-specific phosphorylation of IB by a novel ubiquitination-dependent protein kinase activity. Cell 84, 853-862. 62. Chijiwa, T., Mishima, A., Hagiwara, M., Sano, M., Hayashi, K., Inoue. T., Naito, K., Toshioka, T. and Hidaka, H. (1990) Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D phenochromocytoma cells. J. Biol. Chem. 265, 5267-5272. 63. Chiozzi, P., Murgia, M., Falzoni, S., Ferrari, D., and Di Virgilio, F. (1996) Role of the purinergic P2Z receptor in spontaneous cell death in J774 macrophages cultures. Biochem. Biophys. Res. Commun. 218, 176-181. 64. Chuang, D.M. (1989) Neurotransmitter receptors and phosphoinositide turnover. Ann. Rev. Pharmacol. Toxicol., 29, 71-110. 65. Clark, J.D., Lin, L.L., Kriz, R.W., Ramesha, C.S., Sultzman, L.A., Lin, A.Y., Milona, N. and Knopf, J.L. (1991) A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP. Cell 65, 1043-1051. 66. Cohn, Z.A., and Parks, E. (1967) The regulation of pinocytosis in mouse macrophages, Ⅲ. The induction of vesicle formation by nucleotides and nucleotides. J. Exp. Med. 125, 457-466. 67. Communi, D. and Boeynaems, J.M. (1997) Receptors responsive to extracellular pyrimidine nucleotides. Trends Pharmacol. Sci. 18, 83-86. 68. Communi, D., Parmentier, M., and Boeynaems, J.-M. (1996) Cloning, functional expression and tissue distribuction of the human P2Y6 receptor. Biochem. Biophys. Res. Commun. 222, 303-308. 69. Communi, D., Pirotton, S., Parmentier, M., and Boeynaems, J.M. (1995) Cloning and functional expression of a human uridine nucleotide receptor. J. Biol. Chem. 270, 30849-30852. 70. Communi, D., Raspe, E., Pirotton, S. and Boeynaems, J.M. (1995) Coexpression of P2Y and P2U purinoceptors on aortic endothelial cells. Comparison of cell localization and signaling pathways. Circ. Res. 76, 191-198. 71. Connoly, G.P. and Harrison, P.J. (1994) Reactive blue 2 discriminates between responses medicated by UTP and those evoked by ATP or ,-methylene-ATP on rat sympathetic ganglia. Eur. J. Pharmacol. 259, 95-99. 72. Crack, B.E., Beukers, M.C., Mckechnie, K.C.W., Ijzerman, A.P. and Leff, P. (1994) Pharmacological analysis of ecto-ATPase inhibition: evidence for combined enzyme inhibition and receptor antagonism in P2X-purinoceptor ligands. Br. J. Pharmacol. 113, 1432-1438. 73. Crack, B.E., Pollard, C.E., Beukers, M.W., Roberts, S.M., Hurt, S.F., Ingall, A.H., Mckechnie, K.C.W., Ijzerman, A.P. and Leff, P. (1995) Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibition of ecto-ATPase. Br. J. Pharmacol. 114, 475-481. 74. Cusack, N.J. and Hourani, S. (1991) Design syntheses and pharmacology purinoceptors. Nucleosides Nucleotides 10, 1019-1028. 75. Cusack, N.J. and Hourani, S.M.O. (1982) Specific but non competitive inhibition by 2-alkylthio analogues of adenosine 5''-monophophate and adenosine 5’-triphosphate of human platelet aggregation induced by adenosine 5’-diphosphate. Br. J. Pharmacol. 75, 397-400. 76. Cussack, N. J. (1993) P2 receptor: subclassification and structure-activity relationships. Drug Dev. Res., 28, 244-252. 77. D’Acqisto, F., Iuvone, T., Rombola, L., Sautebin, L., Di. Rosa, M. and Carnuccio. R. (1997) Involvement of NF-B in the regulation of cyclooxgenase-2 protein expression in LPS-stimulated J774 macrophages. FESB Lett. 418, 175-178. 78. Darbon, J.M., Tournier, J.F. Tanber, J.P. and Bayard, F. (1986) Possible role of protein phosphorylation in the mitogenic effect of high density lipoproteins on cultured vascular endothelial cells. J. Biol. Chem. 261, 8002-8008. 79. Davis, P.D., Elliott, L.H., Harris, W., Hill, C.H., Hurst, S.A., Keech, E., Kumar, M.K., Lawton, G., Nixon, J.S., and Wilkinson, S.E. (1992) Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity. J. Med. Chem. 35, 994-1001. 80. Dekker, L.V. and Parker, P.J. (1994) Protein kinase C-a question of specificity. Trends Biochem. Sci. 19, 73-77. 81. Dennis, E.A. (1997) The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem. Sci. 22, 1-2. 82. Dewitt, D. L. (1991) Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim. Biophys. Acta. 1083, 121-134. 83. Di Virgilio, F., Bronte, V., Collavo, D., and Zanovello, P. (1989) Responses of mouse lymphocytes to extracellular adenosine 5’-triphosphate (ATP). Lymphocytes with cytotoxic activity are resistant to the permeability effects of ATP. J. Immunol. 143:1995-1960. 84. Di Virgilio, F., Pizzo, P., Zanovello, P., Bronte, V., and Collavo, D. (1990) Extracellular ATP as a possible mediator of cell-mediated cytotoxicity. Immunol. Today 11, 274-277. 85. Diaz-Guerra, M. J.M., Bodelon, O.G., Velasco, M., Whelan, R., Parker, P.J., and Bosca, L. (1996) Up-regulation of protein kinase C- promotes the expression of cytokine-inducible nitric oxide synthase in RAW 264.7 cells. J. Biol. Chem. 271, 32028-32033. 86. Diaz-Meco, M.T., Dominguez, I., Sanz, L., Dent, P., Lozano, J., Municio, M.M., Berra, E., Hay, R.T., Sturgill, T.W., and Moscat, J. (1994) PKC induces phosphorylation and inactivation of IB- in vitro. EMBO J. 13, 2842-2848. 87. Didonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., and Karin, M. (1997) A cytokine-responsive IB kinase that activates the transcription factor NF-B. Nature 388, 548-554. 88. Drysdale, B.-E., Yapundich, R.A., Shin, M.L., and Shin, H.S. (1987) Lipopolysaccharide-mediated macrophage activation: the role of calcium in the regulation of tumoricidal activity. J. Immunol. 138, 951-956. 89. Dudley, D.T., Pang, L., Decker, S.J., Bridges, A.J. and Saltiel, A.R. (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA. 92, 7686-7689. 90. Duyster, J., Schwende, H., Fitzke, E., Hidaka, G. and Kieter, P. (1993) Different roles of protein kinase C- and - in arachidonic acid cascade, superoxide formation and phosphoinositide hydrolysis. Biochem. J. 292, 203-207. 91. Eberhardt, W., Kunz, D. and Pfeilschifter, J. (1994) Pyrrolidine dithiocarbamate differentially affects interleukin 1- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells. Biochem. Biophys. Res. Commun. 200, 163-170. 92. Edwards, F.A., Gibb, A.J. and Colquhoun, D. (1992) ATP receptor mediated synaptic currents in the central nervous system. Nature 359,144-147. 93. Evans, R.J. and Kennedy, C. (1994) Characterization of P2-purinoceptors in the smooth muscla of the rat tail artery: a comparison between contractile and electrophysiological responses. Br. J. Pharmacol. 113, 853-860. 94. Evans, R.J., Derkach, V. and Surprenant, A. (1992) ATP mediates fast synaptic transmission in mammalian neurons. Nature 357, 503-505. 95. Fischer, B., Boyer, J.L., Hoyle, C.H.V., Ziganshin, A.U., Brizzolara, A.L., Knight, G.E., Zimmet, J., Burnstock, G., Harden, T.K. and Jacobson, K.A. (1993) Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5''-triphosphate. J. Med. Chem. 36, 3937-3946. 96. Flodgaard, H. and Klenow, H. (1982) Abundant amounts of diadenosine 5''-5''''''-P1-P4-tetraphosphate are present and releasable, but metabolically inactive in human platelets. Biochem. J. 208, 737-742. 97. Fournier, T., Riches, D. W., Winston, B. W., Rose, D. M., Young, S. K., Noble, P. W., Lake, F. R. and Henson, P. M. (1995) Divergence in macrophage insulin-like growth factor-I (IGF-I) synthesis induced by TNF- and prostaglandin E2. J. Immunol. 155, 2123-2133. 98. Frantz, B., Nordby, E., Bren, G., Steffan, N., Paya, C., Kincaid, R., Tocci, M., O’Keefe, S., and O’Neill, E. (1994) Calcineurin acts in synergy with PMA to inactivate IB/MAD3, an inhibitor of NF-B. EMBO J. 13, 861-870. 99. Fredholm, B.B., Abbracchio. M.P., Burnstock. G., Daly, J.W., Harden, T.K., Jacobson, K.A., Leff, P. and Williams, M. (1994) Nomenclature and classification of purinoceptros. Pharmacol. Rev. 46, 143-156. 100. Fredholm, B.B., Abbrachio, M.P., Burnstock, G., Dubyak, G.R., Harden, T.K., Jacobson, K.A., Schwabe, U. and Williams, M. (1997) Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol. Sci. 18, 79-82. 101. Fredholm, B.B., Burnstock, G., Harden, T.K. and Spedding, M. (1996) Receptor nomenclature. Drug. Dev. Res. 39, 461-466. 102. Fujihara, M., Connolly, N., Ito, N. and Suzuki, T. (1994) Properties of protein kinase C isoforms (II, , and ) in a macrophage cell line (J774) and their roles in LPS-induced nitric oxide production. J. Immunol. 152, 1898-1906. 103. Gallucci, S., Provenzano, C., Mazzarelli, P., Flavia, S. and Bartoccioni, E. (1997) Myoblasts produce IL-6 in response to inflammatory stimuli. Int. Immunol. 3, 267-27. 104. Gaumond, F., Fortin, D., Stankova, J. and Rola-Pleszcynski, M. (1997) Differential signaling pathways in platelet-activating factorinduced proliferation and interleukin-6 production by rat vascular smooth muscle cells. J. Cardio. Pharmacol. 30, 169-175. 105. George, J.S., Bernard, W.A., Wayne-Albers, R., Perry, B.M. (1995) Basic Neurochemistry, 5th. Raven Press, New York. p. 409. 106. Geppert, T.D., Whitehurst, C.E., Thompson, P., and Beutler, B. (1994) Lipopolysaccharide signal activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway. Mol. Med. 1, 93-103. 107. Goet''z, K., Da Prada, M. and Pletscher, A. (1971) Adenine-, guanine- and uridine-5''-phosphonucleotides in blood platelets and storage organelles of various species. J. Pharmacol. Exp. Ther. 178, 210-215. 108. Goldring, C.E.P., Reveneau, S., Algarte, M, and Jeannin, J.-F. (1996) In vivo footprinting of the mouse inducible nitric oxide synthase gene: inducible protein occupation of numerous sites including Oct and NF-IL6. Nucleic Acids Res. 24, 1682-1687. 109. Goodman, R., Stevens, T.M., Mantegna, L.R., Kidd, P.R., Harris, R.R. and Kerr, J.S. (1991) Phospholipase A2 (PLA2) activity in bovine pulmonary artery endothelial cells. Agents Actions 34, 113-116. 110. Gordon, E.L., Pearon, J.D., Dickson, E.S., Moreau, D. and Slakey, L.L. (1989) The hydrolysis of extracellular adenine nucleotides by arterial smooth muscle cells. Regulation of adenosine production at the cell surface. J. Biol. Chem. 264, 18986-18995. 111. Goss, J.A., Mangino, M.J., Callery, M.P. and Flye, M.W. (1993) Prostaglandin E2 downgulates kupffer cell production of Il-1 and IL-6 during hepatic regulation. Am. J. Physiol. 264, G601-C608. 112. Graeve, L., Baumann, M. and Heinrich, P.C. (1993) Interleukin-6 in autoimmune diseases. Clin. Invest. 71, 664-671 113. Greco, N., Tandon, NN., Jackson, BW., and Jamieson, A.(1992) Low structural specificity for nucleotide triphosphates as an antagonists of ADP-induced platelet activation. J. Biol. Chem. 267, 2966-2970. 114. Griese, M., Gobran, L.J. and Rooney, S.A. (1991) A2 and P2 purine receptor interactions and surfactant secretion in primary cultures of type II cells. Am. J. Physiol. 261, L140-147. 115. Grimble, R.F. (1990) Nutrition and cytokine action. Nutr. Res. Rev. 3, 193-210. 116. Gross, V., Zhang, B., Geng, Y., Villiger, P.M. and Lotz, M. (1994) Regulation of interleukin-6 (IL-6) expression: evidence for a tissue-specific role for protein kinase C. J. Clin. Immunol. 13, 310-320. 117. Grynkiewicz, G., Poenie, M. and Tsien, R.M. (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450. 118. Guan, Z., Baier, L.D., and Morrison, A.R. (1997) p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1. J. Biol. Chem. 272,8083-8089. 119. Habib, A., Bernard, C., Tedgui, A. and Maclouf, J. (1994) Evidence of cross-talks between inducible nitric oxide synthase and cyclooxygenase II in rat peritoneal macrophages. Abstracts of the 9th International Conference on Prostaglandins and Related Compounds. Florence (Italy) June. 6-10, 57. 120. Handler, J.A., Danilowicz, R.M. and Eling, T.E. (1990) Mitogenic signaling by epidermal growth factor (EGF), but not platelet-derived growth factor, requires arachidonic acid metabolism in Balb/c 3T3 cells. J. Biol. Chem. 265, 3669-3673. 121. Harden, T.K., Boyer, J.L. and Nicholas, R.A. (1995) P2-purinergic receptors: subtype-associated signaling responses and structure. Ann. Rev. Pharmacol. & Toxicol. 35, 541-579. 122. Henning, R.H., Duin, M., Den Hertog, H.A. and Nelemans, A. (1993) Characterization of P2-purinoceptor mediated cyclic AMP formation in mouse C2C12 myotubes. Br. J. Pharmacol. 110, 133-138. 123. Hepler, J.R., Earp, H.S. and Harden, T.K. (1998) Long-term phorbol ester treatment down-regulates protein kinase C and sensitizes the phosphoinositide signaling pathway to hormone and growth factor stimulation: evidence for a role of protein kinase C in agonist-induced desensitization. J. Biol. Chem., 263, 7610-7619. 124. Hibbs, J.B. Jr. (1991) Synthesis of nitric oxide from L-arginine: a recently discovered pathway induced by cytokines with antitumour and antimicrobial activity. Res. Immunol. 142, 565- 569. 125. Hinson, R.M., Wiolliams, J.A. and Shacter, E. (1996) Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2. Proc. Natl. Acad. Sci. USA 93, 4885-4890. 126. Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S., Nakajima, K., Koyama, K., Iwamatsu, A., Tsunasawa, S., Sakiyama, F., Matsui, H., Takahara, Y., Taniguchi, T. and Kishimoto, T.(1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324, 73-76. 127. Hourani, S.M.O. and Chown, J.A. (1989) The effects of some possible inhibitors of ectonucleotidases on the breakdown and pharmacological effects of ATP in the guinea-pig urinary bladder. Gen. Pharmacol. 20, 413-416. 128. Hoyle, C.H.V. (1990) Pharmacological activity of adenine dinucleotides in the periphery: possible receptor classes and transmitter function. Gen. Pharmacol. 21, 827-831. 129. Huang, A., Payette, P., Abdullah, K., Cromlish, W.A. and Kennedy, B.P. (1996) Functional identification of the active-site nucleophile of the human 85-kDa cytosolic phospholipase A2. Biochemistry 35, 3712-3721. 130. Hug, H. and Sarre, T.F. (1993) Protein kinase C isoenzymes: divergence in signal transduction? Biochem. J. 291, 329-343. 131. Humphries, R.G., Robertson, M.J. and Leff, P. (1995) A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis. Trends Pharmacol. Sci. 16, 179-181. 132. Inoue, R. and Brading, A.F. (1990) The properties of the ATP-induced depolarization and current in signal cells isolated from the guinea-pig urinary bladder. Br. J. Pharmacol. 100, 619-625. 133. Iwabuchi, K., Hatakeyama, S., Takahashi, A., Ato, M., Okada, M., Kajino Y., Kajino, K. I., Ogasawara, K., Takami, K., Nakagawa, H. and Onoe, K. (1997) Csk overexpression reduces several monokines and nitric oxide productions but enhances prostaglandin E2 production in response to lipopolysaccharide in the macrophage cell line J774A.1. Eur. J. Immunol. 27, 742-749. 134. Iyengar, R. (1993) Molecular and functional diversity of mammalian Gs-stimulated adenylyl cyclases. FASEB J. 7, 768-775. 135. Jacobowitz, O. and Iyengar, R. (1994) Phorbol ester-induced stimulation and phosphorylation of adenylyl cyclase 2. Proc. Nat. Acad. Sci. USA 91, 10630-10634. 136. Jaken, S. (1996) Protein kinase C isozymes and substrates. Curr. Opinion Cell Biol. 8, 168-173. 137. Janosch, P., Schellerer, M., Seitz, T., Reim, P., Eulitz, M., Brielmeier, M., Kolch, W., Sedivy, J.M., and Mischak, H. (1996) Characterization of IB kinases. IB- is not phosphorylated by Raf-1 or protein kinase C isozymes, but is a casein kinase II substrate. J. Biol. Chem. 271, 13868-13874. 138. Jeon, Y. J., Yang, K.-H., Pulaski, J. T. and Kaminski, N. E. (1996) Attenuation of inducible nitric oxide synthase gene expression by 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor-B/Rel activation. Mol. Pharmacol. 50, 334-341. 139. Jiang, C., Ting, A.T. and Seed, B. (1998) RRAP-r agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82-86. 140. Jin, J., Rao Dasari, V., Sistare, F.D. and Kunapuli, S.P. (1998) Distribution of P2Y receptor subtypes on haematopoietic cells. Br. J. Pharmacol., 123, 789-794. 141. Johansson, J., Curstedt, T. and Robertson, B. (1994) The proteins of the surfactant system. Eur. Respir. J. 7, 372-391. 142. Jun, C.D., Choi, B.M., Ryn, H., et al., (1994) Synergistic cooperation between phorbol ester and IFN- for induction of nitric oxide synthesis in murine peritoneal macrophages. J. Immunol. 153, 3684-3690. 143. Kamijo, R., Harada, H., Matsuyama, T., Bosland, M., Gerecitano, J., Shapiro, D., Le, J., Koh, S.I., Kimur, T., Green, S.J., Mak, T.W., Taniguchi, T., and Vilcek, J. (1994) Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263, 1612-1615. 144. Katada, T., Gilman, A.G., Watanabe, Y., Bauer, S. and Jakobs, K.H. (1985) Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylyl cyclase. Eu. J. Biochem. 151, 431-437. 145. Kawabe, J., Iwami, G., Ebina, T., Ohno, S., Katada, T., Ueda, Y., Homcy, C.J. and Ishikawa, Y. (1994) Differential activation of adenylyl cyclase by protein kinase C isoenzymes. J. Biol. Chem. 269, 16554-16658. 146. Keenedy, C. and Leff, P. (1995) How should P2x Purinoceptors be classified pharmacologically? Trends. Pharmacol. Sci. 16, 168-174. 147. Kelm, M. Feelisch, M., Spahr, R., Piper, H.M., Noack, E. and Schrader, J. (1988) Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells. Biochem. Biophys. Res. Commun. 154, 236-244. 148. Keppler, D., Rudiger, J. and Decker, K. (1970) Enzymatic determination of uracil nucleotides in tissues. Anal. Biochem. 38, 105-114. 149. King, B.F., Townsend-Nicholson, A. and Burnstock, G. (1998) Metabotropic receptors for ATP and UTP: exploring the correspondence between native and recombinant nucleotide receptors. Trends Pharmacol. Sci. 19, 506-514. 150. Knowles, R.G., and Moncada, S. (1994) Nitric oxide synthases in mammals. Biochem. J. 298, 249-258. 151. Koide, M., Kawahara, Y., Nakayama, I., Tsuda, T. and Yokoyama, M. (1993) Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. J. Biol. Chem. 268, 24959-24966. 152. Kozawa, O., Suzuki, A. and Uematsu, T. (1997) Basic fibroblast growth factor induces interleukin-6 synthesis in osteoblasts: autoregulation by protein kinase C. Cell Signal. 9, 463-468. 153. Kozawa, O., Suzuki, A., Kaida, T., Tokuda, H. and Uematsu, T. (1997) Tumor necrosis factor-a autoregulates interleukin-6 synthesis via activation of protein kinase C. J. Biol. Chem. 272, 25099-25104. 154. Kozawa, O., Suzuki, A., Shinoda, J., Ozaki, N., Oiso, Y. and Uematsu, T. (1997) Involvement of phospholipase D activation in endothelin-1-induced release of arachidonic acid in osteoblast-like cells. J. Cell. Biochem. 64, 376-381. 155. Kozawa, O., Suzuki, A., Tokuda, H., Kaida, T. and Uematsu, T. (1997) Protein kinase C activation by interleukin (IL)-1 limits IL-1-induced IL-6 synthesis in osteoblast-like cells: involvement of phosphatidylcholine-specific phospholipase C. J. Cell Biochem. 67, 103-111. 156. Kozawa, O., Suzuki, A., Tokuda, H., Kaida, T. and Uematsu, T. (1998) Interleukin-6 synthesis induced by prostaglandin E2: cross-talk regulation by protein kinase C. Bone 22, 355-360. 157. Kozawa, O., Tokuda, H., Kaida, T., Matsuno, H. and Uematsu, T. (1997) Thrombin regulates interleukin-6 synthesis through phosphatidylcholine hydrolysis by phospholipase D in osteoblasts. Arch. Biochem. Biophys. 345, 10-15. 158. Kristhal, O.A., Marchenko, S.M., Obukhov, A.G. and Volkova, T.M. (1988) Receptors for ATP in rat sensory neurones: the structure-function relationship for ligands. Br. J. Pharmacol. 95, 1057-1062. 159. Kunapuli, S.P. (1998) Multiple P2 receptor subtypes on platelets: a new interpretation of their function. Trends Pharmacol. Sci. 19, 391-394. 160. Kunz, D., Muhl, H., Walker, G. and Pfeilschifter, J. (1994) Two distinct signaling pathways trigger the expression of inducible nitric oxide synthase in rat renal mesangial cells. Proc. Natl. Acad. Sci. USA 91, 5387-5391. 161. Kurihara, K., Hosoi, K. and Ueha , T. (1992) Characterization of ecto-nucleoside triphosphatase on A-431 human epidermoidal carcinoma cells. Enzyme 46, 213-220. 162. Kuroda, A., Sugiyama, E., Taki, H., Mino, T. and Kobayashi, M. (1997) Interleukin-4 inhibits the gene expression and biosynthesis of cytosolic phospholipase A2 in lipopolysaccharide stimulated U937 macrophage cell line and freshly prepared adherent rheumatoid synovial cells. Biochem. Biophy. Res. Comm. 230, 40-43. 163. Lai, J.-H., and Tan, T.-H. (1994) CD28 signaling causes a sustained down-regulation of IB which can be prevented by the immunosuppressant rapamycin. J. Biol. Chem. 269, 30077-30080. 164. Lambrecht, G., Friebe, T., Grimm, U., Windscheif, U., Bungardt, E., Hilderbrandt, C., Baumert, H., Spatz-kumbel, G. and Mutschler, E. (1992) PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses. Eur. J. Pharmacol. 217, 217-219. 165. Lapointe, M.C., and Isenovic, E. (1999) IL-1 regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/p44 and p38 MAPK signal pathways in cardiac myocytes. Hypertension. 31, 276-282. 166. Larsson, P. K. A., Claesson, H.-E. and Kennedy, B. P. (1998) Multiple splice variants of the human calcium-independent phospholipase A2 and their effect on enzyme activity. J. Biol. Chem. 273, 207-214. 167. Lazarowski, E.R. and Harden, T.K. (1994). Identification of a uridine nucleotide-selective G-protein-linked receptor that activates phospholipase C. J. Biol. Chem. 269, 11830-11836. 168. Lazarowski, E.R., Homolya, L., Boucher, R.C. and Harden, T.K. (1997) Direct demonstration of mechanically induced release of cellular UTP and its implication for uride nucleotide receptor activation. J. Biol. Chem., 272, 24348-24354. 169. Lazarowski, E.R., Watt, WC., Stutts, M.J., Boucher, R.C., Harden, T.K. (1995) Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate. Br. J. Pharmacol. 116, 1619-1627. 170. Lee, F. S., Hagler, J., Chen, Z. J., and Maniatis, T. (1997) Activation of the IB kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88, 213-222. 171. Lee, F. S., Peters, R. T., Dang, L. C., and Maniatis, T. (1998) MEKK1 activates both IB kinase and IB kinase . Proc. Natl. Acad. Sci. US A 95, 9319-9324. 172. Lee, J.C., Layton, J.T., McDonnell, P.C., Gallagher, T.F., Kumar, S., Green, D., McNulty, D., Blumenthal, M.J., Heys, J.R., Landvatter, S.W., Strickler, J.E., McLaughlin, M.M., Siemerns, I.R., Fisher, S.M., Livi, G.P., White, J.R., Adams, J.L., and Young, P.R. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739-746. 173. Leslie, C.C. (1997) Properties and regulation of cytosolic phospholipase A2. J. Biol. Chem. 272, 16709-16712. 174. Levesque, L., Dean, N. M., Sasmor, D.H. and Crooke, S.T. (1997) Antisense oligonucleotides targeting human protein kinase C- inhibit phorbol ester-induced reduction of bradykinin-evoked calcium mobilization in A549 cells. Mol. Pharmacol. 51, 209-216. 175. Li, H. Oehrlein, S.A. Walleerath, T., Ihrig-Biedert, I., Wohlfart, P., Ulshfer, T., Jessen, T., Herget, T., Forstermann, U. and Kleinert, H. (1998) Activation of protein kinaseC and/or enhances transcription of the human endothelial nitric oxide synthase gene. Mol. Pharmacol. 53, 630-637. 176. Libermann, T.A. and Baltimore, D. (1990) Activation of interleukin-6 gene expression through the NF-B transcription factor. Mol. Cell Biol. 10, 2327-2344. 177. Lin, L.L., Lin, A. and Knopf, J. (1992) Hormonal regulation of cPLA2. Proc. Natl. Acad. Sci. USA 89, 6147-6151. 178. Lin, L.L., Wartmann, M., Lin, A.Y., Knopf, J.L., Seth, A. and Davis, R.J. (1993) cPLA2 is phosphorylated and activated by MAP kinase. Cell 72, 269-278. 179. Lin, S.H. and Guidotti, G. (1989) Cloning and expression of a cDNA coding for a rat liver plasma membrane ecto-ATPase. The primary structure of the ecto-ATPase is similar to that of the human biliary glycoprotein I. J. Biol. Chem. 264, 14408-14414. 180. Lin, W. W. and Chen, B. C. (1997) Involvement of protein kinase C in the UTP-mediated potentiation of cyclic AMP accumulation in mouse J774 macrophages. Br. J. Pharmacol. 121, 1749-1757. 181. Lin, W. W. and Chen, B. C. (1998) Pharmacological comparison of UTP- and thapsigargin-induced arachidonic acid release in RAW 264.7 macrophages. Br. J. Pharmacol. 123, 1173-1181. 182. Lin, W. W. and Lee, Y. T. (1996) Pyrimidinoceptor-mediated activation of phospholipase C and phospholipase A2 in RAW 264.7 macrophages. Br. J. Pharmacol. 119, 261-268. 183. Lin, W. W., Chang, S. H. and Wu, M. L. (1998) Lipoxygenase metabolites as mediators of UTP-induced intracellular acidification in mouse RAW 264.7 macrophages. Mol. Pharmacol. 53, 313-321. 184. Lin, W.W. (1994) Heterogeneity of nucleotide receptors in NG108-15 neuroblastoma and C6 glioma cells for mediating phosphoinositide turnover. J. Neurochem. 62, 536-542. 185. Lin, W.W. (1997) Priming effects of lipopolysaccharide on UTP-induced arachidonic acid release in RAW 264.7 macrophages. Eur. J. Pharmacol. 321, 121-127. 186. Lin, W.W. and Chen, B.C. (1998) Distinct PKC isoforms mediated the activation of cPLA2 and adenylyl cyclase by phorbol ester in RAW 264.7 macrophages. Br. J. Pharmacol., 125, 1601-1609. 187. Lin, W.W. and Chen, B.C. (1998) Pharmacological comparison of UTP- and thapsigargin-induced arachidonic acid release in mouse RAW 264.7 macrophages. Br. J. Pharmacol. 123, 1173-1181. 188. Lin, W.W. and Chuang, D.M. (1992) Regulation of bradykinin-induced phosphoinositide turnover in cultured cerebellar astrocytes: possible role of protein kinase C. Neurochem. Int., 21, 573-579. 189. Lin, W.W. and Chuang, D.M. (1994) Different signal trandsuction pathways are coupled to the nucleotide receptor and the P2Y receptor in C6 glioma cells. J. Pharmacol. Exp. Ther. 269, 926-931. 190. Lin, W.W. and Lee, Y.T. (1996) Pyrimidinoceptor-mediated activation of phospholipase C and phospholipase A2 in RAW 264.7 macrophages. Br. J. Pharmacol. 119, 261-268. 191. Lin, W.W., and Chen B.C. (1998) Pharmacological comparison of UTP- and thapsigargin-induced arachidonic acid release in mouse RAW 264.7 macrophages. Br. J. Pharmacol.123, 1173-1181. 192. Lin, W.W., and Chen, B.C. (1997) Involvement of protein kinase C in the UTP-mediated potentiation of cyclic AMP accumulation in mouse J774 macrophages. Br. J. Pharmacol. 121, 1749-1757. 193. Lin, W.W., Chen, B.C., Hsu, Y.W., Lee, C.M. and Shyue, S.K. (1999) Modulation of iNOS induction by PGE2 in macrophages: distinct susceptibility in murine J774 and RAW 264.7 macrophages. Prostaglandins Lipid Mediators (in press). 194. Lorsbach, R.B., Murphy, W.J., Lowenstein, C.J., Snyder, S.H., and Russell, S.W. (1993) Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon- and lipopolysaccharide. J. Biol. Chem. 268, 1908-1913. 195. Lowenstein, C.J., Alley, E.W., Raval. P., Snowman, A.M., Snyder, S.H., Russell, S.W., and Murphy, W.J. (1993) Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 90, 9730-9734. 196. Lustig, K.D., Erb, L., Landis, D.M., Hicks-Taylor, C.S., Zhang, X., Sportiello, M.G. and Weisman, G.A (1992) Mechanisms by which extracellular ATP and UTP stimulate the release of prostacyclin from bovine pulmonary artery endothelial cells. Biochem. Biophys. Acta 1134, 61-72. 197. MacMicking, J., Xie, Q-W. and Nathan, C. (1997) Nitric oxide and macrophage function. Annu. Rev. Immunol. 15, 323-350. 198. Margolis, R.N., Schell, M.J., Taylor, S.I., and Hubbard, A.L. (1990) Hepatocyte plasma membrane Ecto-ATPase (pp120/HA4) is a substrate for tyrosine kinase activity of the insulin receptor. Biochem. Biophys. Res. Commun. 166, 562-566. 199. Marotta, P., Sautebin, L. and Rosa, M. D. (1992) Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br. J. Pharmacol. 107, 640-641. 200. Martin, C.A. and Dorf, M.E. (1990) Interleukin-6 production by murine macrophage cell lines P388D1 and J774A.1: stimulation requirements and kinetics. Cell. Immunol.128, 555-568. 201. Martin, E., Nathan, C., and Xie, Q-W. (1994) Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180, 977-984. 202. Martin, K.A., Kertesy, S.B. and Dubyak, G.B. (1997) Down-regulation of P2U-purinergic nucleotide receptor messenger RNA expression during in vitro differentiarion of human myeloid leukocytes by phorbol esters or inflammatory activators. Mol. Pharmacol. 51, 97-108. 203. Martin, W., Cusack, N.J., Carleton, J.S. and Gordon, J.L. (1985) Specificity of P2-purinoceptor that mediates endothelium-dependent relaxation of the pig aorta. Eur. J. Pharmacol. 108, 295-299. 204. Martiny-Baron, G., Kazanietz, M.G., Mischak, H., Blumberg, P.M., Kochs, G., Hug, H., Marme, D. and Schachtele, C. (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem, 268, 9194-9197. 205. Matsuno, M., Kozawa, O., Suzuki, A., Tokuda, H., Kaida, T., Matsuno, H., Niwa, M. and Uematsu, T. (1998) Involvement of protein kinase C activation in endothelin-1-induced secretion of interleukin-6 in osteoblast-like cells. Cell Signal 10, 107-111. 206. Matsuoka, I., Zhou, Q., Ishimoto, H. and Nakanishi, H. (1995) Extracellular ATP stimulates adenylyl cyclase and phospholipase C through distinct purinoceptors in NG108-15 cells. Mol. Pharmacol. 47, 855-862. 207. Mattila, P.S., Ullman, K.S., Fiering, S., Emmel, E.A., McCutcheon, M., Crabtree, G.R., and Herzenberg, L.A. (1990) The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J. 9, 4425-4433. 208. Mayer, R.J. and Marshall, L.A. (1993) New insights on mammalian phospholipase A2(s); comparison of arachidonoyl-selective and -nonselective enzymes. FASEB J. 7, 339-348. 209. Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J. W., Young, D. B., Barbosa, M., Manning, A. M., and Rao, A. (1997) IKK-1 and IKK-2:cytokine-activated IB kinases essential for NF-B activation. Science 278, 860-866. 210. Miller, B. W., Baier, L. D. and Morrison, A. R. (1997) Overexpression of protein kinase C- isoform increases cyclooxygenase-2 and inducible nitric oxide synthase. Am. J. Physiol. 273, C130-136. 211. Mochly-Rosen, D. and Gordon, A.D. (1998) Anchoring proteins for protein kinase C: a means for isozyme selectivity. FASEB J. 12, 35-42. 212. Moncada, S., Grhglewski, R., Bunting, S. and Vane, J.R. (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263, 663-665. 213. Moncada, S., Palmer, R.M.J., and Higgs, E.A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142. 214. Mons, N. and Cooper D.M.F. (1995) Adenylate cyclases: critical foci in neuronal signaling. Trends Neurosci. 18, 536-542. 215. Morimoto, B. H. and Koshland, D. E. (1994) Conditional activation of cAMP signal transduction by protein kinase C. The effect of phorbol esters on adenylyl cyclase in permeabilized and intact cells. J. Biol. Chem. 269, 4065-4069. 216. Motte, S., Pirotton, S. and Boeynaems, J.M. Heterogeneity of ATP receptors in aortic endothelial cells. Involvement of P2Y and P2U receptors in inositol phosphate response. Circ. Res. 72, 504-510. 217. Muller-Decker, K. (1989) Interruption of TPA-induced signals by an antiviral and antitumoral xanthate compound: inhibition of a phospholipase C-type reaction. Biochem. Biophys. Res. Commun. 162, 198-205. 218. Mullet, D., Fertel, R.H., Kniss, D., and Cox, G.W. (1997) An increase in intracellular cyclic AMP modulates nitric oxide production in IFN--treated macrophages. J. Immunol. 158, 897-904. 219. Murakami, M., Shimbara, S., Kambe, T., Kuwata, H., M. Winstead, V., Tischfield, J. A. and Kudo, I. (1998) The functions of five distinct mammalian phospholipase A2s in regulating arachidonic acid release. Type IIA and type V secretory phospholipase A2s are functionally redundant and act in concert with cytosolic phospholipase A2. J. Biol. Chem. 273, 14411-14423. 220. Murayama, T., Kajiyama, Y., and Nomura, Y. (1990) Histamine-stimulated and GTP-binding proteins-mediated phospholipase A2 activation in rabbit platelets. J. Biol. Chem. 265, 4290-4295. 221. Naraba, H., Murakami, M., Matsumoto, H., Shimbara, S., Ueno, A., Kudo, I. and Oh-Ishi, S. (1998) Segregated coupling of phospholipase A2, cyclooxygenases, and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages. J. Immunol. 160, 2974-2982. 222. Nathan, C. (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J. 6, 3051-3064. 223. Nathan, C., and Xie, Q.-W.(1994) Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269, 13725-13728. 224. Nathan, C.F. (1987) Secretory products of macrophages. J. Clin. Invest. 79, 319-326. 225. Nathan, C.F. and Hibbs J. Jr. (1991) Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3, 65-70. 226. Naumann, M., and Scheidereit, C. (1994) Activation of NF-B in vivo is regulated by multiple phosphorylations. EMBO J. 13, 4597-4607. 227. Nemenoff, R.A., Winitz, S., Qian, N.X., Van Putten, V., Johnson, G.L. and Heasley, L.E. (1993) Phosphorylation and activation of a high molecualr weight form phospholipase A2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J. Biol. Chem. 268, 1960-1964. 228. Nishizuka, T. (1986) Studies and perspectives of protein kianse C. Science 233, 305-312. 229. Nishizuka, Y. (1984) The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 308, 693-698. 230. Nishizuka, Y. (1986) Studies and perspective of protein kinase C. Science 233, 305-312. 231. Nishizuka, Y. (1992) Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258, 607-614. 232. Nishizuka, Y. (1995) Protein kinase C and lipid signaling for sustained cellular responses. FASEB J, 9, 484-496. 233. Norris, J. L. and Manley, J. L. (1992) Selective nuclear transport of the Drosophila morphogen dorsal can be established by a signaling pathway involving the transmembrane protein Toll and protein kinase C. Gen. Dev. 6, 1654-1667. 234. North, R.A. and Barnard, E.A. (1997) Nucleotide receptors. Curr. Opin. Neurobiol. 7, 346-357. 235. Nuttle, LC., and Dubyak, GR. (1994) Differential activation of cation channels and non-selective pores by macrophage P2Z purinergic receptors expressed in Xenopus oocytes. J. Biol. Chem. 269, 13988-13996. 236. O’Connor, S.E., Dainty, I.A. and Leff, P. (1991) Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol. Sci. 12, 137-141. 237. O’Sullivan, M. G., Chilton, F. H., Huggins, E. M. and McCall, C. E. (1992) Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase. J. Biol. Chem. 267, 14547-14550. 238. Ogle, C.K., Guo, X., Szczur, K., Hartmann, S. and Ogle, J.D. (1994) Production of tumor necrosis factor, interleukin-6 and prostaglandin E2 by LPS-stimulated rat bone marrow macrophages after thremal injury: effect of indomethacin. Inflammation 18, 175-185. 239. Ohno, S., Kawasaki, H., Imajoh, S. and Suzuki, K. (1987) Tissue-specific expression of three distinct types of rabbit protein kinase C. Nature 325, 161-166. 240. Okajima, F., Tokumitsu, Y., Kondo, Y. and Ui, M. (1987) P2-purinergic receptors are coupled to two signal transduction systems leading to inhibition of cAMP generation and to production of inositol trisphosphate in rat hepatocytes. J. Biol. Chem. 262, 13483-13490. 241. Orellana, S., Solski, P.A. and Brown, J.H. (1987) Guanosine 5’-O-(thiotriphosphate)-dependent inositol triphosphate formation in membranes is inhibited by phorbol ester and protein kinase C. J. Biol. Chem. 262, 1638-1643. 242. Osipchuk, Y. and Cahalan, M. (1992) Cell-to-cell spread of calcium signals mediated by ATP receptors in mast cells. Nature 359, 241-244. 243. Pace, J.L., Russell, S.W., Torres, B.A., Johnson, H.M., and Gray, P.W. (1983b) Recombinant mouse interferon- induces the priming step in macrophage activation for tumor cell killing J. Immunol. 130, 2011-2013. 244. Pace, J.L., Russell, S.W., Schreiber, R.D., Altmann, A., and Katz, D.H. (1983a) Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-. Proc. Natl. Acad. Sci. USA 80, 3782-3786. 245. Paglin, S., Roy, R. and Polgar, P. (1993) Characterization of hormonally regulated and particulate-associated phospholipase A2 from bovine endothelial cells. J. Biol. Chem. 268, 11697-11702. 246. Pang, L. and Hoult, J. R. (1997) Repression of inducible nitric oxide synthase and cyclooxygenase-2 by prostaglandin E2 and other cyclic AMP stimulants in J774 macrophages. Biochem. Pharmacol. 53, 493-500. 247. Park, Y.C., Jun, C.D., Kang, H.S., Kim, H.D., Kim, H.M., and Chung, H.T. (1996) Role of intracellular calcium as a priming signal for the induction of nitric oxide synthesis in murine peritoneal macrophages. Immunology 87, 296-302. 248. Parr, C.E., Sullivan, D.M., Paradiso, A.M., Lazarowski, E.R., Burch, L,H., Olsen, J.C., Erb, L., Weisman, G.A., Boucher, R.C. and Turner, J.T. (1994) Cloning and expression of human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Pro. Natl. Acad. Sci. USA 91, 3275-3279. 249. Patel, P., Brown, C. and Boarder, M.R. (1996a) Protein Kinase C isoforms in bovine aortic endothelial cells : role in regulation of P2Y- and P2U-purinoceptor-stimulated prostacyclin release. Br. J. Pharmacol. 118, 123-130. 250. Patel, V., Brown, C., Goodwin, A., Wilkie, N. and Boarder, M.R. (1996b) Phosphorylation and activation of p42 and p44 mitogen-activated protein kinase are required for the P2 purinoceptor stimulation of endothelial prostacyclin production. Biochem. J. 320, 221-226. 251. Paul, A., Pendreigh, R.H., and Plevin, R. (1995) Protein kinase C and tyrosine kinase pathways regulate lipopolysaccharide-induced nitric oxide synthase activity in RAW 264.7 murine macrophages. Br. J. Pharmacol. 114, 482-488. 252. Pintor, J., Torres, M., Castro, E. and Miras-Portugal, M.T. (1991) Characterization of diadenosine tetraphossphate (AP4A) binding sites in cultured chromaffin cells: evidence for a P2Y site. Br. J. Pharmacol. 103, 1980-1984. 253. Pirotton, S., Lecomte, M., Robaye, B., DeMolle, D., Van Coevorden, A., Nairn, A.C. and Boeynaems, J.M. (1990) P2-purinergic receptors on vascular endothelial cells: Transduction mechanisms. Ann. NY Acad. Sci. 603, 480-483. 254. Pison, U., Max, M., Neuendank, A., Weissbach, S. and Pietschmann, S. (1994) Host defence capacities of pulmonary surfactant: evidence for “non-surfactant” functions of the surfactant system. Eur. J. Clin. Invest. 24, 586-599. 255. Post, S.R., Jacobson, J.P. and Insel, P.A. (1996) P2 purinergic receptor agonists enhance cAMP production in Madin-Darby canine kidney epithelial cells via an autocrine/paracrinemechanism. J. Biol. Chem. 271, 2029-2032. 256. Pruimboom, W.M., van Dijk., J. A.P.M., Tak, C.J.A.M., Garrelds, I., Bonta, I.L., Wilson, P.J.H. and Zijlstra, F.J. (1994) Interaction between cytokines and eicosanoids: a study using human peritoneal macrophages. Immunol. Lett. 41, 255-260. 257. Purkiss, J.R., West, D., Wilkes, L.C., Scott, C., Yarrow, P., Wilkinson, G.F. and Boarder, M.R. (1994) Stimulation of phospholipase C in cultured microvascular endothelial cells from human frontal lobe by histamine, endotheilin and purinoceptor agonists. Br. J. Pharmacol. 111, 1041-1046. 258. Purkiss, J.R., Wilkinson, G.F. and Boarder, M.R. (1994) Different regulation of inositol 1,4,5-trisphosphate by co-existing P2Y-purinoceptors and nucleotide receptors on bovine aortic endothelial cells. Br. J. Pharmacol. 111, 723-728. 259. Qiu, Z.H., De Carvalho, M.S. and Leslie, C.C. (1993) Regulation of phospholipase A2 activation by phosphorylation in mouse peritoneal macrophages. J. Biol. Chem. 268, 24506-24513. 260. Quinn, M.T., Parathasarathy, S. and Steinberg, D. (1988) Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc. Natl. Acad. Sci. USA 85, 2805-2809. 261. Raddassi, K., Petit, J. F. and Lemaire, G. (1993) LPS-induced activation of primed murine peritoneal macrophages is modulated by prostaglandins and cyclic nucleotides. Cell. Immunol. 149, 50-64. 262. Ralveic, V. and Burnstock, G. (1996) Discrimination by PPADS between endothelial P2X- and P2U-purinoceptors in the rat isolated mesenteric bed. Br. J. Pharmacol. 118, 428-434. 263. Regnier, C.H., Song, H.Y., Gao, X. Goeddel, D.V., Cao, Z., and Rothe, M. (1997) Identification and characterization of an IB kinase. Cell 90, 373-383. 264. Ridley, S.H., Sarafield, S.J., Lee, J.C., Bigg, H.F., Cawston, T.E., Taylor, D.J., DeWitt, D.L., and Saklatvala, J. (1997) Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J. Immunol. 158, 3165-3173. 265. Roco, L.P., and Meltzer, M.S. (1978) Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of sequence of short-lived intermediary reactions. J. Immunol. 121, 2035-2042. 266. Rodriguez del Castillo, A., Torres, M., delicado, E.G.and Miras-Portugal, M.T. (1988) Subcellular distribution studies of diadenosine polyphosphates-AP4A and AP5A-in bovine adrenal medulla: presence in chromaffin granules. J. Neurochem. 51, 1696-1703. 267. Rola-Pleszczynski, M. and Stankova, J. (1992) Leukotriene B4 enhances interleukin-6 (IL-6) production and IL-6 messenger RNA accumulation in human monocytes in vitro: transcriptional and posttranscriptional mechanisms. Blood 80, 1004-1011. 268. Rooney, S.A. (1990) Type II cell purinoceptors and surfactant section. Prog. Respir. Res. 25, 127-135. 269. Rougier, F., Cornu, E., Praloran, V. and Denizot, Y. (1998) IL-6 and IL-8 production by human bone marrow stromal cells. Cytokine 10, 93-97. 270. Sa, G. and Fox, P.L. (1994) Basic fibroblast growth factor-stimulated endothelial cell movement is mediated by a pertussis toxin-sensitive pathway regulating phospholipase A2 activity. J. Biol. Chem. 269, 3219-3225. 271. Salvemini, D., Korbut, R., Anggard, E., and Vane., J. (1990) Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA 87, 2593-2597. 272. Salvemini, D., Misko, T. P., Masferrer, J. L., Seibert, K., Currie, M. G. and Needleman, P. (1993) Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA 90, 7240-7244. 273. Sands, W.A., Clark, J.S., and Liew, F.Y. (1994) The role of a phosphatidylcholine-specific phospholipase C in the production of diacylglycerol for nitric oxide synthesis in macrophages activated by IFN- and LPS. Biochem. Biophys. Res. Commun. 199, 461-466. 274. Sato, K., Okajima, F. and Kondo, Y. (1992) Extracellular ATP stimulates three different receptor-signal transduction systems in FRTL-5 thyroid cells. Activation of phospholipase C, and inhibition and activation of adenylate cyclase. Biochem. J. 283, 281-287. 275. Schievella, A.R., Regier, M.K., Smith, W.L. and Lin, L.L. (1995) Calcium-mediated translocation of cytosolic phospholipase A2 to the nuclear envelope and endoplasmic reticulum. J. Biol. Chem. 270, 30749-30754. 276. Schouten, G.J., Vertegaal, A.C.O., Whiteside, S.T. Israel, A., Toebes, M., Dorsman, J.C., van der Eb. A.J., and Zantema, A. (1997) IB is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J. 16, 3133-3144. 277. Schreck, R. Rieber, P., and Baeuerle, P. A. (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-B transcription factor and HIV-1. EMBO J. 10, 2247-2258. 278. Schreck, R., Meier, B., Mannel, D.N., Droge, W., and Baeuerle, P.A. (1992) Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 175, 1181-1194. 279. Sehgal, P.B., Walther, Z. and Tamm, I. (1987) Rapid enhancement of 2-interferon/B-cell differentiation factor BSF-2 gene expression in human fibroblasts by diacylglycerols and the calcium ionophore A23187. Proc. Natl. Acad. Sci. USA 84, 3663-3667. 280. Seifert, R. and Schultz, G. (1989) Involvement of pyrimidinoceptors in the regulation of cell functions by uridine and by uracil nucleotides. Trends Pharmacol. Sci. 10, 365-369. 281. Serkkola, E. and Hurme, M. (1993) Activation of NF-B by cAMP in human myeloid cells. FEBS Lett. 334, 327-330. 282. Severn, A., Wakelam, M.J.O., and Liew, F.Y. (1992) The role of protein kinase C in the induction of nitric oxide synthesis by murine macrophages. Biochem. Biophys. Res. Commun. 188, 997-1002. 283. Shirakawa, F. and Mizel, S. B. (1989) In vitro activation and nuclear translocation of NF-B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol. Cell. Biol. 9, 2424-2430. 284. Siebenlist, U., Franzoso, G., and Brown, K. (1994) Structure, regulation and function of NF-B. Ann. Rev. Cell Biol. 10, 405-455. 285. Sippel, C.J., Suchy, F.J., Ananthanarayanan, M. and Perlmutter, D.H. (1990) The rat liver ecto-ATPase is also a canalicular bile acid transport protein. J. Biol. Chem. 268, 2083-2091. 286. Smith, J.A.M., Webb, C., Holford, J. and Burgess, G.M. (1995) Signal transduction pathways for B1 and B2 bradykinin receptors in bovine pulmonary artery endothelial cells. Mol. Pharmacol. 47, 525-534. 287. Smith, R.J., Sam, L.M., Justen, J.M., Bundy, G.L., Bala, G.A., and Bleasdale, J.E. (1990) Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness. J. Pharmacol. Exp. Ther. 253, 688-697. 288. Sodhi, A., and Kumar, R. (1994) Int. J. Immunolpathol. Pharmacol. 7, 65-77. 289. Somers, S.D., Weiel, J.E., Hamilton, T.A., and Adams, D.O. (1986). Phorbol esters and calcium ionophore can prime murine peritoneal macrophage for tumor cells destruction. J. Immunol. 136, 4199-4205. 290. Sowa, G., and Przewlocki, R. (1994) cAMP analogues and cholera toxin stimulate the accumulation of nitrite in rat peritoneal macrophage cultures. Eur. J. Pharmacol. 266, 125-129. 291. Spangelo, B.L., Isakson, P.C., and MacLeod, R.M. (1990) Production of interleukin-6 by anterior pituitary cells is stimulated by intracellular adenosine 3’,5’-monophosphate and vasoactive intestinal peptide. Endocrinology 127, 403-409. 292. Spriggs, D.R., Deutsch, S. and Kufe, D.W. (1991) Genomic structure, induction, and production of TNF-a. In The Cytokine Handbook. ed. Thompson, A.W. pp.1-34. London: Academic Press. 293. Stadler, J., Racic, M. S., Billiar, T. R., Curran, R. D., Mcintyre, L. A., Georgescu, H. I., Simmons, R. L. and Evans., C. H. (1991) Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J. Immunol. 147, 3915-3920. 294. Steffan, N.M., Bren, G.D., Frantz, B., Tocci, M.J., O’Neill, E.A., and Paya, C.V. (1995) Regulation of IB phosphorylation by PKC- and Ca2+-dependent signal transduction pathways. J. Immunol. 155, 4685-4691. 295. Stratman, N. C., Carter, D. B. and Sethy, V. H. (1997) Ibuprofen: effect on inducible nitric oxide synthase. Brain Res.-Mol. Brain Res. 50, 107-112. 296. Streb, H., Irvine, R.F., Berridge, M.J. and Schulz, I. (1983) Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature 306, 67-69. 297. Sugiyama, K. (1971) Calcium-dependent histamine release with degranulation from isolated rat mast cells Jpn. J. Pharmacol. 84, 165-173. 298. Sumi, M., Kiuchi, K., Ishikawa, T., Ishii, A., Hagiwara, M., Nagatsu, T., and Hidaka, G. (1991) The newly synthesized selective Ca2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells. Biochem. Biophys. Res. Commun. 181, 968-975. 299. Sunahara, R.K., Dessauer, C.W. and Gilman, A.G. (1996) Complexity and diversity of mammalian adenylyl cyclases. Ann. Rev. Pharmacol. Toxicol. 36, 461-480. 300. Sung, S.J., and Silverstein, S.C. (1985) Inhibition of macrophage phagocytosis by methylation inhibitors. J. Biol. Chem. 260, 546-554. 301. Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., and Buell, G. (1996) The cytolytic P2Z receptor for extracellular ATP indentified as a P2X receptor (P2X7). Science 272:735-738. 302. Tada, S., Okajima, F., Mitsui, Y., Kondo, Y. and Ui, M. (1992) P2 purinoceptor-mediated cyclic AMP accumulation in bovine vascular smooth muscle cells. Eur. J. Pharmacol. 227, 25-31. 303. Taussig, R. and Gilman, A.G. (1995) Mammalian membrane-bound adenylyl cyclas
|